Showing results (1391-1400 of 4,992) with videos related to

Sort By:
Pageof 500
Headache|January 31, 2019
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine HeadachesStewart J Tepper, David W Dodick, Peter C Schmidt, et al.
Headache|December 10, 2020
Understanding What People With Migraine Consider to be Important Features of Migraine Tracking: An Analysis of the Utilization of Smartphone-Based Migraine Tracking With a Free-Text FeatureMia T Minen, Jana Jaran, Talia Boyers, et al.
Headache|November 29, 2020
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With MigraineJanet H Ford, Tobias Kurth, Amaal J Starling, et al.
Headache|November 5, 2013
Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trialShadi Asadollahi, Kamran Heidari, Reza Vafaee, et al.
Headache|March 22, 2021
Developmental innervation of cranial dura mater and migraine headache: A narrative literature reviewAndrew Witten, Dario Marotta, Aaron Cohen-Gadol
Headache|March 22, 2021
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysisAndrew M Blumenfeld, Peter J Goadsby, David W Dodick, et al.
Headache|March 22, 2021
Baseline sleep quality, stress, and depressive symptoms, and subsequent headache occurrence in a six-week prospective cohort study of patients with episodic migraineAngeliki Vgontzas, Wenyuan Li, Elizabeth Mostofsky, et al.
Headache|December 28, 2021
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine DiaryRichard B Lipton, Pranav Gandhi, Jonathan Stokes, et al.
Headache|March 23, 2021
The association between inflammatory bowel disease and migraine or severe headache among US adults: Findings from the National Health Interview Survey, 2015-2016Yong Liu, Fang Xu, Anne G Wheaton, et al.
Headache|March 25, 2021
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraineFumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.
Pageof 500